Velaglucerase alfa for Gaucher disease in Japan: Long-term post-marketing surveillance data from a unique population with high rates of neuronopathic subtypes
- DOI
- 10.1016/j.ymgmr.2026.101373
- Published
- 2026-12
- Container
- Molecular Genetics and Metabolism Reports
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ymgmr.2026.101373,
title = {Velaglucerase alfa for Gaucher disease in Japan: Long-term post-marketing surveillance data from a unique population with high rates of neuronopathic subtypes},
author = {Miyako Hoshino and Kei Murayama and Hiroyuki Ida and Erika Asano and Hiromichi Otaka},
year = {2026},
journal = {Molecular Genetics and Metabolism Reports},
doi = {10.1016/j.ymgmr.2026.101373},
url = {https://doi.org/10.1016/j.ymgmr.2026.101373}
}RIS
TY - JOUR TI - Velaglucerase alfa for Gaucher disease in Japan: Long-term post-marketing surveillance data from a unique population with high rates of neuronopathic subtypes AU - Miyako Hoshino AU - Kei Murayama AU - Hiroyuki Ida AU - Erika Asano AU - Hiromichi Otaka PY - 2026 JO - Molecular Genetics and Metabolism Reports DO - 10.1016/j.ymgmr.2026.101373 UR - https://doi.org/10.1016/j.ymgmr.2026.101373 ER -
APA
Hoshino, M., Murayama, K., Ida, H., Asano, E., & Otaka, H. (2026). Velaglucerase alfa for Gaucher disease in Japan: Long-term post-marketing surveillance data from a unique population with high rates of neuronopathic subtypes. Molecular Genetics and Metabolism Reports. https://doi.org/10.1016/j.ymgmr.2026.101373
Source records
- crossref · retrieved 2026-11-10T14:17:20.077Z